APPARATUS AND METHOD FOR DETERMINING PROGNOSIS OF BREAST CANCER AND WHETHER TO USE CHEMOTHERAPY

The present invention relates to an apparatus and method for determining the prognosis of breast cancer and whether to use chemotherapy and, more specifically, to an apparatus and method capable of predicting a necessary prognosis and chemotherapeutic effects in determining the cancer treatment dire...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: PAIK SOON-MYUNG
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PAIK SOON-MYUNG
description The present invention relates to an apparatus and method for determining the prognosis of breast cancer and whether to use chemotherapy and, more specifically, to an apparatus and method capable of predicting a necessary prognosis and chemotherapeutic effects in determining the cancer treatment direction for breast cancer using progesterone receptor immunostaining results and Ki67 protein immunostaining results. The method for determining the prognosis of breast cancer of the present invention can be performed at lower costs compared with a conventional method for determining the prognosis of breast cancer, and can provide a normalized index in predicting the prognosis of breast cancer and the chemotherapeutic effect due to relatively high accuracy, and thus finally can contribute to the improvement in national health and welfare. 本发明涉及种用于测定乳腺癌预后以及是否使用化疗的装置和方法,更具体地,涉及种能够利用孕酮受体的免疫染色结果和Ki67蛋白的免疫染色结果,在确定乳腺癌的肿瘤治疗方向中预测必要的预后和化疗效果的装置和方法。与用于测定乳腺癌预后的常规方法相比,本发明的测定乳腺癌预后的方法可以低成本进行,并且由于其相对高的准确性,能够提供用于预测乳腺癌预后和化疗效果的标准化指标,最终
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN107430133A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN107430133A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN107430133A3</originalsourceid><addsrcrecordid>eNqNi0EKwjAQRbNxIeodxgMILRFcj-m06SKZMEkprkqRuBIt1PtjFQ_g6n0e_63VgCGgYOoioK_AUbJcQc0CFSUS1_rWNxCEG8-xjcA1nIUwJjDoDcm36u2SLTsxdJHAWHL8ERguW7W6jfc5737cqH1NydhDnp5Dnqfxmh_5NRhfFqejLkqtUf_zeQNAJjL9</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>APPARATUS AND METHOD FOR DETERMINING PROGNOSIS OF BREAST CANCER AND WHETHER TO USE CHEMOTHERAPY</title><source>esp@cenet</source><creator>PAIK SOON-MYUNG</creator><creatorcontrib>PAIK SOON-MYUNG</creatorcontrib><description>The present invention relates to an apparatus and method for determining the prognosis of breast cancer and whether to use chemotherapy and, more specifically, to an apparatus and method capable of predicting a necessary prognosis and chemotherapeutic effects in determining the cancer treatment direction for breast cancer using progesterone receptor immunostaining results and Ki67 protein immunostaining results. The method for determining the prognosis of breast cancer of the present invention can be performed at lower costs compared with a conventional method for determining the prognosis of breast cancer, and can provide a normalized index in predicting the prognosis of breast cancer and the chemotherapeutic effect due to relatively high accuracy, and thus finally can contribute to the improvement in national health and welfare. 本发明涉及种用于测定乳腺癌预后以及是否使用化疗的装置和方法,更具体地,涉及种能够利用孕酮受体的免疫染色结果和Ki67蛋白的免疫染色结果,在确定乳腺癌的肿瘤治疗方向中预测必要的预后和化疗效果的装置和方法。与用于测定乳腺癌预后的常规方法相比,本发明的测定乳腺癌预后的方法可以低成本进行,并且由于其相对高的准确性,能够提供用于预测乳腺癌预后和化疗效果的标准化指标,最终</description><language>chi ; eng</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171201&amp;DB=EPODOC&amp;CC=CN&amp;NR=107430133A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20171201&amp;DB=EPODOC&amp;CC=CN&amp;NR=107430133A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PAIK SOON-MYUNG</creatorcontrib><title>APPARATUS AND METHOD FOR DETERMINING PROGNOSIS OF BREAST CANCER AND WHETHER TO USE CHEMOTHERAPY</title><description>The present invention relates to an apparatus and method for determining the prognosis of breast cancer and whether to use chemotherapy and, more specifically, to an apparatus and method capable of predicting a necessary prognosis and chemotherapeutic effects in determining the cancer treatment direction for breast cancer using progesterone receptor immunostaining results and Ki67 protein immunostaining results. The method for determining the prognosis of breast cancer of the present invention can be performed at lower costs compared with a conventional method for determining the prognosis of breast cancer, and can provide a normalized index in predicting the prognosis of breast cancer and the chemotherapeutic effect due to relatively high accuracy, and thus finally can contribute to the improvement in national health and welfare. 本发明涉及种用于测定乳腺癌预后以及是否使用化疗的装置和方法,更具体地,涉及种能够利用孕酮受体的免疫染色结果和Ki67蛋白的免疫染色结果,在确定乳腺癌的肿瘤治疗方向中预测必要的预后和化疗效果的装置和方法。与用于测定乳腺癌预后的常规方法相比,本发明的测定乳腺癌预后的方法可以低成本进行,并且由于其相对高的准确性,能够提供用于预测乳腺癌预后和化疗效果的标准化指标,最终</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi0EKwjAQRbNxIeodxgMILRFcj-m06SKZMEkprkqRuBIt1PtjFQ_g6n0e_63VgCGgYOoioK_AUbJcQc0CFSUS1_rWNxCEG8-xjcA1nIUwJjDoDcm36u2SLTsxdJHAWHL8ERguW7W6jfc5737cqH1NydhDnp5Dnqfxmh_5NRhfFqejLkqtUf_zeQNAJjL9</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>PAIK SOON-MYUNG</creator><scope>EVB</scope></search><sort><creationdate>20171201</creationdate><title>APPARATUS AND METHOD FOR DETERMINING PROGNOSIS OF BREAST CANCER AND WHETHER TO USE CHEMOTHERAPY</title><author>PAIK SOON-MYUNG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN107430133A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2017</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>PAIK SOON-MYUNG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PAIK SOON-MYUNG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>APPARATUS AND METHOD FOR DETERMINING PROGNOSIS OF BREAST CANCER AND WHETHER TO USE CHEMOTHERAPY</title><date>2017-12-01</date><risdate>2017</risdate><abstract>The present invention relates to an apparatus and method for determining the prognosis of breast cancer and whether to use chemotherapy and, more specifically, to an apparatus and method capable of predicting a necessary prognosis and chemotherapeutic effects in determining the cancer treatment direction for breast cancer using progesterone receptor immunostaining results and Ki67 protein immunostaining results. The method for determining the prognosis of breast cancer of the present invention can be performed at lower costs compared with a conventional method for determining the prognosis of breast cancer, and can provide a normalized index in predicting the prognosis of breast cancer and the chemotherapeutic effect due to relatively high accuracy, and thus finally can contribute to the improvement in national health and welfare. 本发明涉及种用于测定乳腺癌预后以及是否使用化疗的装置和方法,更具体地,涉及种能够利用孕酮受体的免疫染色结果和Ki67蛋白的免疫染色结果,在确定乳腺癌的肿瘤治疗方向中预测必要的预后和化疗效果的装置和方法。与用于测定乳腺癌预后的常规方法相比,本发明的测定乳腺癌预后的方法可以低成本进行,并且由于其相对高的准确性,能够提供用于预测乳腺癌预后和化疗效果的标准化指标,最终</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN107430133A
source esp@cenet
subjects INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
title APPARATUS AND METHOD FOR DETERMINING PROGNOSIS OF BREAST CANCER AND WHETHER TO USE CHEMOTHERAPY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T22%3A07%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PAIK%20SOON-MYUNG&rft.date=2017-12-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN107430133A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true